Larvol Delta - Centrexion-Therapeutics-Announces-Completion-of-Patient-Enrollment-in-VICTORY3-Phase-3-OpenLabel-Clinical-Trial-of-CNTX4975-in-Patients-with-ModeratetoSevere-Osteoarthritis-Knee-Pain

Adlea (capsaicin) - Arcion, Centrexion

http://www.globenewswire.com/news-release/2019/09/17/1916594/0/en/Centrexion-Therapeutics-Announces-Completion-of-Patient-Enrollment-in-VICTORY-3-Phase-3-Open-Label-Clinical-Trial-of-CNTX-4975-in-Patients-with-Moderate-to-Severe-Osteoarthritis-Kn.html

Sep 17, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next